Amnion-derived cells, methods of making and uses thereof
AssigneeStemnion, Inc.
InventorsCharlotte Emig, Vivienne S Marshall
Life of this patent
Estimating the term…
Abstract
The invention is directed to substantially purified amnion-derived cell populations, compositions comprising the substantially purified amnion-derived cell populations, and to methods of creating such substantially purified amnion-derived cell populations, as well as methods of use. The invention is further directed to antibodies, in particular, monoclonal antibodies, that bind to amnion-derived cells or, alternatively, to one or more amnion-derived cell surface protein markers. The invention is further directed to methods for producing the antibodies, methods for using the antibodies, and kits comprising the antibodies.
Claims6
A cosmetic preparation comprising:
- a) a substantially purified population of cultured amnion-derived epithelial cells that is made by the method comprising the steps of
- i) obtaining a placenta and isolating an amnion from the placenta,
- ii) enzymatically releasing amnion-derived epithelial cells from the amnion,
- iii) collecting the released amnion-derived epithelial cells, and
- iv) culturing the collected amnion-derived epithelial cells of step (c) in basal culture medium that is supplemented with human serum albumin and recombinant human EGF;
- and
- b) a gelling agent.
Dependencies are inferred from the claim text.